hydroxyurea - Generic mfg.
|
bleximenib (JNJ-6617) - J&J
|
pevonedistat (MLN4924) - Takeda
|
Venclexta (venetoclax) - Roche, AbbVie
|
BI 836858 - Boehringer Ingelheim
|
SRA515 - GSK
|
Xospata (gilteritinib) - Astellas
|
dubermatinib (TP-0903) - Sumitomo Pharma
|
Tibsovo (ivosidenib) - Servier
|
idarubicin hydrochloride - Generic mfg.
|
azacitidine - Generic mfg.
|
decitabine - Generic mfg.
|
cytarabine - Generic mfg.
|
Idhifa (enasidenib) - BMS, Servier
|
entospletinib (GS-9973) - Ignota Labs
|
Revuforj (revumenib) - Syndax Pharma
|
lomonitinib (ZE46-0134) - Lomond Therapeutics
|
ficlatuzumab (AV-299) - AVEO Oncology
|
AZD5991 - AstraZeneca
|
daunorubicin - Generic mfg.
|
samalizumab (ALXN 6000) - The Leukemia & Lymphoma Society, AstraZeneca
|